Company / Net Income
REGENXBIO Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$193.9M
FY2025
5-year range
-$280.3M / -$94.7M
FY2021-FY2025
Trend
+14.6%
vs FY2024
Sector context
#153 of 216
Health Care
What the data says
At -$194M, REGENXBIO Inc.'s net income ranks #153 of 216 in the Health Care sector. Net Income has increased for 3 consecutive years, from -$280M in FY2022 to -$194M in FY2025.
Based on SEC 10-K filings.
-$194M in FY2025.
Improved from -$263M to -$194M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#153 of 216 in Health CareTop 71% of 216This company -$193.9M Sector average $454.1M
▼
-142.7% below sector average
Key checks
Key Insights
- REGENXBIO Inc.'s net income has grown for 3 consecutive years.
- In FY2025, net income increased 14.6% year-over-year.
- Ranks #153 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$193.9M | +14.6% |
| FY2024 | -$227.1M | +13.8% |
| FY2023 | -$263.5M | +6.0% |
| FY2022 | -$280.3M | -195.9% |
| FY2021 | -$94.7M | -194.8% |
| FY2020 | $99.9M | +236.6% |
| FY2019 | -$73.2M | -173.2% |
| FY2018 | $99.9M | +236.6% |
| FY2017 | -$73.2M | -1727.9% |
| FY2016 | -$4.0M | +25.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026